Medicare Enrolled
Dr. Evelyn Mendoza, M.D.
Optician · Hemet, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mendoza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mendoza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mendoza
Dr. Evelyn Mendoza is an optician specialist in Hemet, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mendoza performed 321,407 Medicare services across 4,467 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mendoza received a total of $24,885 from 101 pharmaceutical and/or device companies across 994 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mendoza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in CA
$24,885 industry payments
Medicare Practice Summary
Medicare Utilization ↗321,407
Medicare services
Top 0% in CA for optician
4,467
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16,070 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
133,500 | $1 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
19,360 | $6 | $14 |
| Denosumab injection (Prolia/Xgeva) | 17,580 | $17 | $22 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
15,480 | $37 | $61 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
15,400 | $0 | $3 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
14,790 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 13,400 | $43 | $57 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
11,200 | $0 | $0 |
| Cemiplimab injection, 1 mg This code represents the administration of a 1 mg dose of cemiplimab, a medication delivered via injection. |
10,850 | $21 | $34 |
| Injection, immune globulin (bivigam), 500 mg | 8,110 | $56 | $80 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 7,901 | $0 | $0 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
6,410 | $6 | $15 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
6,336 | $26 | $41 |
| Paclitaxel chemotherapy injection | 5,862 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 4,160 | $1 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,152 | $0 | $0 |
| Injection, granisetron, extended-release, 0.1 mg | 4,100 | $5 | $7 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
3,887 | $4 | $55 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,994 | $11 | $15 |
| Rituximab-arrx biosimilar injection, 10 mg An injection of rituximab-arrx, a biosimilar medication, administered in a 10 mg dose. |
1,920 | $35 | $95 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,880 | $1 | $13 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,812 | $8 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,551 | $96 | $131 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,341 | $3 | $3 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,123 | $12 | $16 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
1,010 | $1 | $5 |
| Injection, leucovorin calcium, per 50 mg | 763 | $3 | $13 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
517 | $110 | $139 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 459 | $3 | $14 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
437 | $55 | $69 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
417 | $2 | $7 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
318 | $1 | $2 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
314 | $7 | $12 |
| Pegfilgrastim-fpgk biosimilar injection, 0.5 mg An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg. |
312 | $274 | $384 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
293 | $2 | $7 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
292 | $17 | $21 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
275 | $61 | $77 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
189 | $55 | $68 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
160 | $21 | $29 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
155 | $3 | $10 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
138 | $28 | $36 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
130 | $139 | $184 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
122 | $24 | $30 |
| New patient office visit, complex (60-74 min) | 113 | $171 | $225 |
| Injection, triptorelin pamoate, 3.75 mg | 101 | $296 | $407 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 97 | $10 | $14 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
79 | $20 | $28 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
78 | $24 | $30 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
70 | $63 | $80 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
62 | $74 | $104 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
53 | $47 | $59 |
| Refilling and maintenance of portable pump This service involves refilling and performing maintenance on a portable pump. |
48 | $107 | $135 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
46 | $1 | $1 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 41 | $339 | $615 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
40 | $17 | $21 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
39 | $102 | $131 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
36 | $11 | $13 |
| Injection, alteplase recombinant, 1 mg | 34 | $67 | $101 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
23 | $2 | $3 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
20 | $151 | $190 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
16 | $29 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $74 | $93 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
46.6% high complexity
51.7% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,885
Total received (2018-2024)
Avg $3,555/year across 7 years
Top 8% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
101
Companies
994
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,766 (75.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,900 (11.7%)
Other
Charitable contributions, space rental, and other categories
$2,260 (9.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$959 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,683
2023
$3,701
2022
$4,297
2021
$2,107
2020
$3,032
2019
$2,973
2018
$4,092
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,493
Janssen Biotech, Inc.
$301
Daiichi Sankyo Inc.
$253
Merck Sharp & Dohme LLC
$249
E.R. Squibb & Sons, L.L.C.
$236
PFIZER INC.
$191
AstraZeneca Pharmaceuticals LP
$172
SOBI, INC
$152
ABBVIE INC.
$125
Celgene Corporation
$118
BeiGene USA, Inc.
$114
Eisai Inc.
$105
Alexion Pharmaceuticals, Inc.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$87
Incyte Corporation
$81
Blueprint Medicines Corporation
$76
Agios Pharmaceuticals, Inc.
$75
Verity Pharmaceuticals Inc.
$74
Astellas Pharma US Inc
$72
GlaxoSmithKline, LLC.
$61
TAIHO ONCOLOGY, INC.
$55
Genmab U.S., Inc.
$53
Mirati Therapeutics, Inc.
$44
Lilly USA, LLC
$43
ARRAY BIOPHARMA INC
$40
Immunocore Limited
$34
Karyopharm Therapeutics Inc.
$28
Tempus AI, Inc
$27
Pharmacosmos Therapeutics Inc.
$26
Ipsen Biopharmaceuticals, Inc
$24
Dendreon Pharmaceuticals LLC
$24
Stemline Therapeutics Inc.
$24
Genentech USA, Inc.
$24
Gilead Sciences, Inc.
$22
EMD Serono, Inc.
$20
ACCORD HEALTHCARE, INC.
$20
PUMA BIOTECHNOLOGY, INC.
$19
Coherus Biosciences Inc.
$19
Exelixis Inc.
$16
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,906
AstraZeneca Pharmaceuticals LP
$2,353
Seagen Inc.
$2,164
Janssen Biotech, Inc.
$1,927
E.R. Squibb & Sons, L.L.C.
$1,136
PFIZER INC.
$1,097
Merck Sharp & Dohme LLC
$789
Seattle Genetics, Inc.
$649
Daiichi Sankyo Inc.
$550
Amgen Inc.
$538
GENZYME CORPORATION
$524
Takeda Pharmaceuticals U.S.A., Inc.
$489
Merck Sharp & Dohme Corporation
$427
Genentech USA, Inc.
$424
Incyte Corporation
$421
NOVARTIS PHARMACEUTICALS CORPORATION
$375
Astellas Pharma US Inc
$356
Alexion Pharmaceuticals, Inc.
$327
Celgene Corporation
$321
Lilly USA, LLC
$260
Karyopharm Therapeutics Inc.
$248
Pharmacyclics LLC, An AbbVie Company
$230
Pharmacyclics LLC, an AbbVie Company
$222
SOBI, INC
$220
Eisai Inc.
$219
BeiGene USA, Inc.
$215
ABBVIE INC.
$201
Exelixis Inc.
$196
Gilead Sciences, Inc.
$185
Coherus Biosciences Inc.
$181
Bayer HealthCare Pharmaceuticals Inc.
$178
Blueprint Medicines Corporation
$177
GlaxoSmithKline, LLC.
$177
EMD Serono, Inc.
$172
Taiho Oncology, Inc.
$161
ARRAY BIOPHARMA INC
$160
JAZZ PHARMACEUTICALS INC.
$158
AMAG Pharmaceuticals, Inc.
$124
Teva Pharmaceuticals USA, Inc.
$117
Foundation Medicine, Inc.
$113
Verity Pharmaceuticals Inc.
$110
Regeneron Healthcare Solutions, Inc.
$108
Intuitive Surgical, Inc.
$105
Verastem, Inc.
$103
EISAI INC.
$102
Puma Biotechnology, Inc.
$100
Helsinn Therapeutics (U.S.), Inc.
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
Sobi, Inc
$95
Kite Pharma, Inc.
$93
Mirati Therapeutics, Inc.
$93
Acrotech Biopharma LLC
$90
Ipsen Biopharmaceuticals, Inc
$83
AbbVie Inc.
$79
Stemline Therapeutics Inc.
$77
Janssen Pharmaceuticals, Inc
$77
Agios Pharmaceuticals, Inc.
$75
Rigel Pharmaceuticals, Inc.
$74
Mylan Institutional Inc.
$66
Myriad Genetic Laboratories, Inc.
$66
TG THERAPEUTICS, INC.
$64
ACCORD HEALTHCARE, INC.
$62
Dendreon Pharmaceuticals LLC
$58
AbbVie, Inc.
$56
TAIHO ONCOLOGY, INC.
$55
Genmab U.S., Inc.
$53
Adaptive Biotechnologies Corporation
$52
TerSera Therapeutics LLC
$51
Bayer Healthcare Pharmaceuticals Inc.
$48
Shire North American Group Inc
$46
EUSA Pharma (US) LLC
$46
PUMA BIOTECHNOLOGY, INC.
$45
MorphoSys, US Inc.
$43
Clovis Oncology, Inc.
$42
Otsuka America Pharmaceutical, Inc.
$41
Epizyme, Inc.,
$41
Kyowa Kirin, Inc.
$40
CSL Behring
$40
Octapharma USA, Inc.
$35
Immunocore Limited
$34
TESARO, Inc.
$30
Partner Therapeutics, Inc.
$28
Tempus AI, Inc
$27
Pharmacosmos Therapeutics Inc.
$26
Apellis Pharmaceuticals, Inc.
$25
ABIOMED
$24
Grifols USA, LLC
$23
Array BioPharma Inc.
$23
Jazz Pharmaceuticals Inc.
$23
ADC Therapeutics America, Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$21
Aurobindo Pharma USA, Inc.
$21
West Therapeutics Development, LLC
$21
Organon LLC
$20
Dova Pharmaceuticals
$20
Deciphera Pharmaceuticals Inc.
$19
BTG International, Inc.
$17
Global Blood Therapeutics, Inc.
$16
Secura Bio, Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$16
Telix Pharmaceuticals
$14
Top 3 companies account for 29.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY · ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALOXI · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRACAnalysis CDx · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CHANTIX · COSELA · CROFAB · CYRAMZA · Cabometyx · Copiktra · DALVANCE · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAZYVA · GILOTRIF · Herceptin · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Idelvion · Imbruvica · Impella · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Leukine · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Thrombate III · Trelstar · Trodelvy · Truxima · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vanflyta · Vectibix · Venclexta · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xtandi · YERVOY · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · ZYTIGA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in CA.
Geographic Context
Opticians within 10 mi
88
Per 100K population
3.6
County median income
$89,672
Nearest hospital
HEMET GLOBAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mendoza is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 8% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mendoza experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Mendoza performed 133,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mendoza receive payments from pharmaceutical companies?
Yes. Dr. Mendoza received a total of $24,885 from 101 companies across 994 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mendoza's costs compare to other opticians in Hemet?
Dr. Mendoza's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mendoza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Hemet
Browse opticians in Hemet ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology